Student or educator? Sign up with your school email and get 6 months of Pro free.
PreprintCited by 272

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

Open access
Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba, Bogdanovic, Gordana, Muschiol, Sandra, Wullimann, David J., Kammann, Tobias, Emgård, Johanna, Parrot, Tiphaine, Folkesson, Elin, Rooyackers, Olav, Eriksson, Lars I., Sönnerborg, Anders, Allander, Tobias, Albert, Jan, Nielsen, Morten, Klingström, Jonas, Gredmark-Russ, Sara, Björkström, Niklas K., Sandberg, Johan K., Price, David A., Ljunggren, Hans-Gustaf, Aleman, Soo, Buggert, Marcus, Karolinska COVID-19 Study Group·2020·bioRxiv (Cold Spring Harbor Laboratory)

Preprint — published as 10.1016/j.cell.2020.08.017 · Paper page

Abstract

SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.06.29.174888

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 45

  1. Alshukairi, A.N. , Khalid, I. , Ahmed, W.A. , Dada, A.M. , Bayumi, D.T. , Malic, L.S. , Althawadi, S. , Ignacio, K. , Alsalmi, H.S. , Al-Abdely, H.M. , et al. (2016). Antibody Response and Disease Severity in Healthcare Worker MERS Survivors. Emerg Infect Dis 22. · DOI
  2. 10.1182/blood-2005-12-4818 · DOI · Paper page
  3. 10.4049/jimmunol.1202234 · DOI
  4. 2018, Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease, PLoS Pathog, 14, e1006973, 10.1371/journal.ppat.1006973 · DOI
  5. Buggert, M. , Nguyen, S. , Salgado-Montes de Oca, G. , Bengsch, B. , Darko, S. , Ransier, A. , Roberts, E.R. , Del Alcazar, D. , Brody, I.B. , Vella, L.A. , et al. (2018b). Identification and characterization of HIV-specific resident memory CD8(+) T cells in human lymphoid tissue. Sci Immunol 3. · DOI · Paper page
  6. 10.4049/jimmunol.1302253 · DOI
  7. 10.1371/journal.ppat.1004251 · DOI · Paper page
  8. Chandrashekar, A. , Liu, J. , Martinot, A.J. , McMahan, K. , Mercado, N.B. , Peter, L. , Tostanoski, L.H. , Yu, J. , Maliga, Z. , Nekorchuk, M. , et al. (2020). SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. · DOI · Paper page
  9. 1996, Human cytotoxic T-cell memory: long-lived responses to vaccinia virus, J Virol, 70, 2627, 10.1128/jvi.70.4.2627-2631.1996 · DOI · Paper page
  10. 10.1126/scitranslmed.aaa3700 · DOI · Paper page
  11. Grifoni, A. , Weiskopf, D. , Ramirez, S.I. , Mateus, J. , Dan, J.M. , Moderbacher, C.R. , Rawlings, S.A. , Sutherland, A. , Premkumar, L. , Jadi, R.S. , et al. (2020). Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. · DOI · Paper page
  12. 2020, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 · DOI · Paper page
  13. 10.1136/bmj.m2376 · DOI
  14. 2020, The clinical course and its correlated immune status in COVID-19 pneumonia, J Clin Virol, 127, 104361, 10.1016/j.jcv.2020.104361 · DOI · Paper page
  15. 2020, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nat Med, 26, 672, 10.1038/s41591-020-0869-5 · DOI · Paper page
  16. Hotez, P.J. , Corry, D.B. , Strych, U. , and Bottazzi, M.E. (2020). COVID-19 vaccines: neutralizing antibodies and the alum advantage. Nat Rev Immunol. · DOI
  17. 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  18. Kirkcaldy, R.D. , King, B.A. , and Brooks, J.T. (2020). COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. · DOI · Paper page
  19. 10.4049/jimmunol.181.8.5490 · DOI · Paper page
  20. 10.1016/j.ebiom.2020.102763 · DOI · Paper page
  21. Long, Q.X. , Tang, X.J. , Shi, Q.L. , Li, Q. , Deng, H.J. , Yuan, J. , Hu, J.L. , Xu, W. , Zhang, Y. , Lv, F.J. , et al. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. · DOI · Paper page
  22. 10.1038/d41586-020-01115-z · DOI · Paper page
  23. 10.1016/j.immuni.2008.02.020. · DOI · Paper page
  24. Ni, L. , Ye, F. , Cheng, M.L. , Feng, Y. , Deng, Y.Q. , Zhao, H. , Wei, P. , Ge, J. , Gou, M. , Li, X. , et al. (2020). Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. · DOI · Paper page
  25. Nina Le Bert, A.T.T. , Kamini Kunasegaran , Christine Y L Tham , Morteza Hafezi , Adeline Chia , Melissa Chng , Meiyin Lin , Nicole Tan , Martin Linster , Wan Ni Chia , Mark I-Cheng Chen , Lin-Fa Wang , Eng Eong Ooi , Shirin Kalimuddin , Paul Anantharajal Tambyah , Jenny Guek-Hong Low Yee-Joo Tan and Antonio Bertoletti (2020). Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals. bioRxiv. · DOI
  26. 2020, Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?, Clin Chim Acta, 509, 1, 10.1016/j.cca.2020.05.050 · DOI
  27. 10.1084/jem.20062363 · DOI · Paper page
  28. 10.1084/jem.20051357 · DOI · Paper page
  29. Reynisson, B. , Alvarez, B. , Paul, S. , Peters, B. , and Nielsen, M. (2020). NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. · DOI · Paper page
  30. Robbiani, D.F. , Gaebler, C. , Muecksch, F. , Lorenzi, J.C.C. , Wang, Z. , Cho, A. , Agudelo, M. , Barnes, C.O. , Gazumyan, A. , Finkin, S. , et al. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals. bioRxiv. · DOI
  31. Seydoux, E. , Homad, L.J. , MacCamy, A.J. , Parks, K.R. , Hurlburt, N.K. , Jennewein, M.F. , Akins, N.R. , Stuart, A.B. , Wan, Y.H. , Feng, J. , et al. (2020). Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual. bioRxiv. · DOI
  32. 2019, Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection, Clin Infect Dis, 68, 984, 10.1093/cid/ciy595 · DOI
  33. 10.1001/jama.2016.0287 · DOI · Paper page
  34. 10.4049/jimmunol.0903490 · DOI · Paper page
  35. 2020, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat Med, 26, 453, 10.1038/s41591-020-0819-2 · DOI · Paper page
  36. 10.1038/s41467-020-16256-y · DOI · Paper page
  37. 10.15585/mmwr.mm6914e1 · DOI · Paper page
  38. Wilk, A.J. , Rustagi, A. , Zhao, N.Q. , Roque, J. , Martinez-Colon, G.J. , McKechnie, J.L. , Ivison, G.T. , Ranganath, T. , Vergara, R. , Hollis, T. , et al. (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. · DOI
  39. Woloshin, S. , Patel, N. , and Kesselheim, A.S. (2020). False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. N Engl J Med. · DOI · Paper page
  40. Wu, Z. , and McGoogan, J.M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. · DOI · Paper page
  41. 10.1016/j.clim.2006.05.002 · DOI
  42. 2020, Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China, JAMA Netw Open, 3, e2010182, 10.1001/jamanetworkopen.2020.10182 · DOI · Paper page
  43. Zhao, J. , Alshukairi, A.N. , Baharoon, S.A. , Ahmed, W.A. , Bokhari, A.A. , Nehdi, A.M. , Layqah, L.A. , Alghamdi, M.G. , Al Gethamy, M.M. , Dada, A.M. , et al. (2017). Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol 2. · DOI · Paper page
  44. 10.1016/j.immuni.2016.05.006 · DOI · Paper page
  45. 10.1038/s41423-020-0401-3 · DOI · Paper page

Cited by

See all 272

Metadata

Authors
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., Wullimann, D. J., Kammann, T., Emgård, J., Parrot, T., Folkesson, E., Rooyackers, O., Eriksson, L. I., Sönnerborg, A., Allander, T., Albert, J., Nielsen, M., Klingström, J., Gredmark-Russ, S., Björkström, N. K., Sandberg, J. K., Price, D. A., Ljunggren, H.-G., Aleman, S., Buggert, M., & Karolinska COVID-19 Study Group
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2020-06-29
OpenAlex
W3037695843
Cited by
272
References
4
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. https://app.cochat.ai/papers/10.1101/2020.06.29.174888
The paper
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., Wullimann, D. J., Kammann, T., Emgård, J., Parrot, T., Folkesson, E., Rooyackers, O., Eriksson, L. I., Sönnerborg, A., Allander, T., . . . Karolinska COVID-19 Study Group. (2020). Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.06.29.174888

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.